Aew Capital Management L P Makes New $230,000 Investment in Global Medical REIT Inc. (NYSE:GMRE)

Aew Capital Management L P bought a new position in Global Medical REIT Inc. (NYSE:GMREFree Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 29,820 shares of the company’s stock, valued at approximately $230,000.

A number of other hedge funds also recently made changes to their positions in GMRE. JPMorgan Chase & Co. raised its holdings in shares of Global Medical REIT by 54.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 231,927 shares of the company’s stock worth $2,298,000 after acquiring an additional 81,596 shares in the last quarter. Franklin Resources Inc. lifted its position in Global Medical REIT by 228.9% during the third quarter. Franklin Resources Inc. now owns 114,988 shares of the company’s stock valued at $1,073,000 after purchasing an additional 80,030 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Global Medical REIT by 158.6% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 120,614 shares of the company’s stock worth $1,195,000 after buying an additional 73,965 shares in the last quarter. Barclays PLC raised its position in shares of Global Medical REIT by 87.1% during the 3rd quarter. Barclays PLC now owns 154,051 shares of the company’s stock valued at $1,527,000 after buying an additional 71,704 shares in the last quarter. Finally, FMR LLC lifted its holdings in shares of Global Medical REIT by 39.5% in the 3rd quarter. FMR LLC now owns 184,550 shares of the company’s stock valued at $1,829,000 after acquiring an additional 52,281 shares during the last quarter. 57.52% of the stock is currently owned by hedge funds and other institutional investors.

Global Medical REIT Trading Up 4.1 %

Shares of NYSE GMRE opened at $8.83 on Friday. The stock has a market capitalization of $589.67 million, a P/E ratio of -441.13, a PEG ratio of 1.43 and a beta of 1.24. Global Medical REIT Inc. has a 1-year low of $7.33 and a 1-year high of $10.46. The business’s 50 day moving average is $7.97 and its two-hundred day moving average is $8.75. The company has a debt-to-equity ratio of 1.26, a current ratio of 0.28 and a quick ratio of 0.28.

Global Medical REIT (NYSE:GMREGet Free Report) last issued its quarterly earnings results on Thursday, February 27th. The company reported $0.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.01 by $0.21. Global Medical REIT had a return on equity of 0.86% and a net margin of 3.23%. The company had revenue of $35.16 million during the quarter, compared to the consensus estimate of $34.87 million. As a group, research analysts expect that Global Medical REIT Inc. will post 0.81 EPS for the current year.

Global Medical REIT Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 9th. Investors of record on Friday, March 21st will be issued a dividend of $0.21 per share. The ex-dividend date is Friday, March 21st. This represents a $0.84 annualized dividend and a yield of 9.52%. Global Medical REIT’s payout ratio is -4,200.00%.

Global Medical REIT Company Profile

(Free Report)

Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.

Featured Articles

Want to see what other hedge funds are holding GMRE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Global Medical REIT Inc. (NYSE:GMREFree Report).

Institutional Ownership by Quarter for Global Medical REIT (NYSE:GMRE)

Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.